DZP advised ARRA GROUP on transaction of TransPharma International BV joining group as investor

DZP advised ARRA GROUP on the transaction of TransPharma International BV joining the group as a strategic investor.

TransPharma International BV, a member company of the Walden Group, provides forwarding solutions compliant with the Good Distribution Practice for the healthcare industry.

Our client ARRA GROUP is a logistics service provider that specialises in the transport of pharmaceuticals and other products under controlled temperature conditions. The company operates on the domestic and international markets and, owing to acquiring the new investor, will expand the range of its services, thus continuing its growth strategy.

We supported ARRA Group in almost the entire investment process, from structuring the transaction to negotiations, to cooperation in drafting the investment agreement governing transaction terms and post-transaction cooperation between the parties.

Jakub Wieszczeczyński and Klaudia Bartoszyńska-Kwiatkowska were key transaction advisers. They were supported by Piotr Andrzejczak, Ariel Sławiński and Zuzanna Popielarz from the Corporate and M&A Practice, Joanna Wierzejska from the Tax Practice and Jarosław Łukawski from the Competition Law Team.